MK-4448

· Portola Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MK-4448, covering 2017-09-18 to 2017-09-18. Get the full timeline:

Most recent: Clinical Trial Update: Evaluate the Pharmacokinetics and Safety of MK-4448 in Participants With Nonvalvular Atrial Fibrillation or Atrial Flutter [Phase 2]

See pricing